SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001636050-23-000013
Filing Date
2023-03-17
Accepted
2023-03-16 21:36:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A siox8-k03152023.htm DEFA14A 32739
  Complete submission text file 0001636050-23-000013.txt   33986
Mailing Address 1501 BROADWAY 12TH FLOOR NEW YORK NY 10036
Business Address 1501 BROADWAY 12TH FLOOR NEW YORK NY 10036 877-746-4891
Sio Gene Therapies Inc. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 853863315 | Fiscal Year End: 0331
Type: DEFA14A | Act: 34 | File No.: 001-37418 | Film No.: 23740556
SIC: 2834 Pharmaceutical Preparations